Our Expert Team
A diverse group of scientists, analysts, and industry experts dedicated to advancing biotech intelligence and market insights.
Dr. Forsyth
Founder & CEO
Dr. Forsyth initially studied economics and political science in a B Comm program. After MD and FP training, he founded a successful medical practice in Raleigh, NC, and maintained an interest in financial investing and current economic and political events. He is now a full-time investor focusing on growth companies. Like many smaller focused investors, he has outperformed the conventional averages handily. He has been very concerned with the state of general health in the country and will use this platform to help focus on solutions. He has aligned himself with a brilliant young biotech molecular scientist to try to stratify the complex world of emerging biotech. The risks are high, but the results can be lucrative.
Dr. Srishti Gupta
chief scientific officer
Dr. Srishti Gupta is the Chief Science Officer (CSO) at Mindreader Enterprises, where she leads the company’s scientific vision and strategy. She holds a Ph.D. in Biological sciences from Colorado State University and a Master’s degree in Biotechnology. Her research background spans molecular biology, protein biochemistry, and cell biology, with extensive experience in recombinant protein expression, RNA sequencing, and functional genomics. At Mindreader, she leverages her scientific training to evaluate biotechnology pipelines, analyze emerging therapies, and translate complex research into actionable insights for investors.
Dr. Joshua Dloomy, MD
Chief Technology Officer
Dr. Joshua Dloomy serves as Chief Technology Officer (CTO) at Mindreader Enterprises, bringing a unique blend of medical expertise, technological vision, and market insight. With deep knowledge of human immunology, a passion for biotech innovation, and strong experience in trading and market analysis, he drives the company’s technology strategy and research platforms. At Mindreader, Dr. Dloomy combines his clinical background with biotech market expertise to ensure that our analyses and tools are scientifically robust and strategically aligned with industry needs.
Taina Kirk
Administrator